[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Liquidia Corp (LQDA)

Liquidia Corp (LQDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,989,048
  • Shares Outstanding, K 89,509
  • Annual Sales, $ 158,320 K
  • Annual Income, $ -68,920 K
  • EBIT $ 169 M
  • EBITDA $ 170 M
  • 60-Month Beta 0.53
  • Price/Sales 38.54
  • Price/Cash Flow N/A
  • Price/Book 31.27

Options Overview Details

View History
  • Implied Volatility 105.14% (-0.33%)
  • Historical Volatility 57.76%
  • IV Percentile 35%
  • IV Rank 28.61%
  • IV High 185.25% on 10/31/25
  • IV Low 73.04% on 05/21/26
  • Expected Move (DTE 2) 5.53 (8.10%)
  • Put/Call Vol Ratio 1.59
  • Today's Volume 13,075
  • Volume Avg (30-Day) 15,351
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 221,609
  • Open Int (30-Day) 196,539
  • Expected Range 62.65 to 73.70

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.82
  • Number of Estimates 3
  • High Estimate $1.01
  • Low Estimate $0.66
  • Prior Year $-0.04
  • Growth Rate Est. (year over year) +2,150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
66.10 +4.83%
on 09/01/26
93.61 -25.97%
on 08/11/26
-14.82 (-17.61%)
since 07/31/26
3-Month
53.06 +30.60%
on 06/03/26
93.61 -25.97%
on 08/11/26
+14.18 (+25.74%)
since 06/02/26
52-Week
21.15 +227.71%
on 09/26/25
93.61 -25.97%
on 08/11/26
+40.71 (+142.46%)
since 09/02/25

Most Recent Stories

More News
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress

MORRISVILLE, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging...

LQDA : 69.76 (+4.26%)
Liquidia to Present Posters at the European Respiratory Society (ERS) 2026 Congress

MORRISVILLE, N.C., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging...

LQDA : 69.76 (+4.26%)
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

MORRISVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer and Chief Financial Officer, and Jason Adair, Chief...

LQDA : 69.76 (+4.26%)
Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference

MORRISVILLE, N.C., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) today announced that Michael Kaseta, Chief Operating Officer...

LQDA : 69.76 (+4.26%)
WFC : 89.29 (+2.59%)
Liquidia Corporation Reports Second Quarter 2026 Financial Results

YUTREPIA ® (treprostinil) inhalation powder net product sales of approximately $170.4 million in the second quarter of 2026, up 31% from the first quarter of 2026 Approximately 5,900 unique patient...

LQDA : 69.76 (+4.26%)
Liquidia Corporation Reports Second Quarter 2026 Financial Results

Liquidia Corporation Reports Second Quarter 2026 Financial Results

LQDA : 69.76 (+4.26%)
Liquidia's First Profitable Quarter: Is the Thesis Finally Working or Just Good Timing?

Barchart Research What to Expect from LQDA Earnings LQDA Generated August 11, 2026 Current Price $88.05 EPS Estimate $$0.70 Consensus Rating Strong Buy Average Move 6.55% Liquidia's First Profitable Quarter:...

LQDA : 69.76 (+4.26%)
This Little-Known Stock Has Surged 360% in the Past Year

Liquidia (LQDA) exhibits exceptional momentum with shares up more than 360% over the past 52 weeks. LQDA holds a 100% “Buy” technical opinion, with multiple analyst ratings supporting strong bullish...

LQDA : 69.76 (+4.26%)
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

MORRISVILLE, N.C., July 29, 2026 (GLOBE NEWSWIRE) -- Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging...

LQDA : 69.76 (+4.26%)
Liquidia Corporation to Report Second Quarter 2026 Financial Results on August 12, 2026

Liquidia Corporation (Nasdaq: LQDA) announced today that it will report its second quarter 2026 financial results on Wednesday, August 12, 2026....

LQDA : 69.76 (+4.26%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Liquidia Corporation is a biopharmaceutical company. It develops, manufactures and commercializes products for unmet patient needs principally in the United States. Liquidia Corporation, formerly known as LIQUIDIA TECHNL, is based in Morrisville, North Carolina.

See More

Key Turning Points

3rd Resistance Point 71.47
2nd Resistance Point 70.24
1st Resistance Point 68.57
Last Price 69.76
1st Support Level 65.67
2nd Support Level 64.44
3rd Support Level 62.77

See More

52-Week High 93.61
Last Price 69.76
Fibonacci 61.8% 65.93
Fibonacci 50% 57.38
Fibonacci 38.2% 48.83
52-Week Low 21.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.